Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis

Stroke

Volumn 27, Issue 10, 1996, Pages 1724-1730

  Deschiens, Marie Anne ^a   Conard, Jacqueline ^b   Horellou, Marie Hélène ^b   Ameri, Alain ^c   Preter, Maurice ^a   Chedru, François ^c   Samama, Meyer Michel ^b   Bousser, Marie Germaine ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b HÔTEL DIEU   (France)

^c CENTRE HOSPITALIER DE MEAUX   (France)

Author keywords

antiphospholipid antibodies; cerebral veins; coagulation; thrombophilia; venous thrombosis

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; CARDIOLIPIN ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE PREDISPOSITION; FEMALE; GENETIC DISORDER; HUMAN; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR; THROMBOPHILIA; THROMBOSIS PREVENTION; VEIN THROMBOSIS;

EID: 0029768068     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.10.1724     Document Type: Article

References (41)

1. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin. 1992;10:87-111.
2. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA. 1993;90: 1004-1008.
3. Bertina RM, Koeleman BPMC, Koster T, Rosendaal FR, Dirven RJ, De Ronde H, Van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67.
4. Koster T, Rosendaal FR, de Ronde F, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor response to activated protein C: Leiden thrombophilia study. Lancet. 1993;342:1503-1506.
5. Trossaërt M, Conard J, Horellou MH, Samaha M, Elalamy I, Samama MM. Résistance à la protéine C activée dans les accidents thromboemboliques veineux: fréquence et manifestations cliniques. Presse Méd. 1995;24:209-212.
6. Daif A, Awada A, Al-Rajeh S, Abuljabbar M, Al Tahan AR, Obeid T, Malibary T. Cerebral venous thrombosis in adults: a study of 40 cases from Saudi Arabia. Stroke. 1995;26:1193-1195.
7. Einhaüpl KM, Masuhr F. Cerebral venous and sinus thrombosis: an update. Eur J Neurol. 1994;1:109-126.
8. Preter M, Tzourio C, Ameri A, Bousser MG. Long-term prognosis in cerebral venous thrombosis: follow-up of 77 patients. Stroke. 1996;27:243-246.
9. Trossaërt M, Conard J, Horellou MH, Samama M, Ireland H, Bayston TA, Lane DA. Modified APC resistance assay for patients on oral anticoagulants. Lancet. 1994;344:1709. Letter.
10. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957;17:237-246.
11. Barthelemy M, Bousser MG, Jacobs C. Thrombose veineuse cérébrale au cours d'un syndrome néphrotique. Nouv Presse Med. 1980; 9:367-369.
12. Estanol B, Rodriguez A, Conte G, Aleman JM, Loyo M, Pizzuto J, Intracranial venous thrombosis in young women. Stroke. 1979;10: 680-684.
13. Cantu C, Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium: review of 67 cases. Stroke. 1993;24:1880-1884.
14. Engesser L, Broekmans AW, Briët E, Bromer EJP, Bertina RM. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med. 1987;106:677-682.
15. Cros D, Comp P, Beltramn G, Gum G. Superior sagittal sinus thrombosis in a patient with protein S deficiency. Stroke. 1990;21:633-636.
16. Heistinger M, Rumpl E, Illiasch H, Turck H, Kyrle PA, Lechner K, Pabinger I. Cerebral sinus thrombosis in a patient with hereditary protein S deficiency: case report and review of the literature. Ann Hematol. 1992;64:105-109.
17. Prats JM, Garaizar C, Zuavo E, Lopez J, Pinan MA, Aragües P. Superior sagittal sinus thrombosis in a child with protein S deficiency. Neurology. 1992;42:2303-2305.
18. Moreb J, Kitchens CG. Acquired functional protein S deficiency, cerebral venous thrombosis, and coumarin skin necrosis in association with antiphospholipid syndrome: report of two cases. Am J Med. 1989;87:207-210.
19. Comp PC. Thurnau GR, Welsh J, Esmon CT. Functional and immunologic protein S levels are decreased during pregnancy. Blood. 1986;68:881-885.
20. Huisveld IA, Hospers JEH, Meijers JCM, Starkenburg AE, Erich WBM, Bouma BN. Oral contraceptives reduce total protein S but not free protein S. Thromb Res. 1987;45:109-114.
21. Eon B, Aknin P, Brun JP, Saux P, Gouin F. Protein C deficiency and cerebral venous thrombosis in pregnancy. Ann Fr Anesth Reanim. 1987;106:677-682.
22. Enevoldson TP, Ross Russell RW. Cerebral venous thrombosis: new causes for an old syndrome. Q J Med. 1990;284:1255-1275.
23. Harle JR, Aillaud MF, Quinsat D, Habib M, Boude P, Tafani B, Weiller PJ, Mongin M. Thrombophlébite cérébrale révélatrice d'un déficit fonctionnel en protéine C. Ann Med Interne. 1989;140: 233-234.
24. Vieregge P, Schwieder G, Kompf D. Cerebral venous thrombosis in hereditary protein C deficiency. Neurol Neurosurg Psychiatry. 1989; 52:135-137.
25. Confavreux C, Brunet P, Petiot P, Berruyer M, Trillet M, Aimard G. Congenital protein C deficiency and superior sagittal sinus thrombosis causing isolated intracranial hypertension. J Neurol Neurosurg Psychiatry. 1994;57:655-657.
26. Ambruso DR, Jacobson LJ, Hathaway WE. Inherited antithrombin III deficiency and cerebral thrombosis in a child. Pediatrics. 1980; 65:125-131.
27. Sauron B, Chiras J, Chain G, Castaigne P. Thrombophlébite cérébelleuse chez un homme porteur d'un déficit familial en antithrombine III. Rev Neurol. 1982;138:685. Letter.
28. Thaler E, Lechner K. Antithrombin III deficiency and thrombo-embolism. Clin Haematol. 1981;10:369-390.
29. Broekmans AW, Conard J. Hereditary protein C deficiency. In: Bertina RM, ed. Protein C and Related Proteins. New York, NY: Churchill Livingstone Inc; 1988:160-181.
30. Bridey F, Wolff M, Laissy JP, Morin V, Lefebvre M, de Prost D. Fatal cerebral venous sinus thrombosis associated with the factor V Leiden mutation and the use of oral contraceptives. Thromb Haemost. 1995;74:1382. Letter.
31. Martinelli I, Landi G, Merati G, Cella R. Tosetto A, Mannucci PM. Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost. 1996;75:393-394.
32. Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden. Lancet. 1994;344:1453-1457.
33. van Boven HA, Reitsma PH, Rosendaal FR, Bayston TA, Chowdury V, Bauer KA, Scharrer I, Conard J, Lane D. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thromb Haemost. 1996;75:417-421.
34. Koeleman BPC, Reitsma PH, Allart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood. 1994;84:1031-1035.
35. Zöller B, Berntsdotter A, Garcia de Frutos P, Dahlbäck B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood. 1995;85:3518-3523.
36. Levine SR, Kieran S, Puzio K, Feit H, Patel SC, Welch KMA. Cerebral venous thrombosis with lupus anticoagulants: report of two cases. Stroke. 1987;18:801-804.
37. Cumming AM, Tait RC, Fildes S, Yoong A, Keeney S, Hay CRM. Development of resistance to activated protein C during pregnancy. Br J Haematol. 1995;90:725-727.
38. Henkens CMA. Bom VJJ, Seinen AJ, van der Meer J. Sensitivity to activated protein C: influence of oral contraceptives and sex. Thromb Haemost. 1995;73:402-404.
39. Dahlbäck B. Resistance to activated protein C, the Arg 506 to Gln mutation in the factor V gene, and venous thrombosis. Thromb Haemost. 1995;73:739-742.
40. Vidailhet M, Piette JC, Wechsler B, Bousser MG, Brunet P. Cerebral venous thrombosis in systemic lupus erythematosus. Stroke. 1990; 21:1226-1231.
41. Wechsler B, Vidailhet M, Piette JC, Bousser MG, Dell Isola B, Bletry O, Godeau P. Cerebral venous thrombosis in Behçet's disease: clinical study and long-term follow-up of 25 cases. Neurology. 1992; 42:614-618.